Skip to main content
Clinical Trials/DRKS00027218
DRKS00027218
Not yet recruiting
Not Applicable

Covid-19 in patients with inflammatory bowel diseases: rates and courses of infection, rates of vaccination, potential side effects and antibody titers - An evaluation at the outpatient clinic for IBD of the University Hospital Heidelberg - Covid19CED

niversitätsklinikum Heidelberg0 sites400 target enrollmentNovember 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid-19Inflammatory Bowel Diseases
Sponsor
niversitätsklinikum Heidelberg
Enrollment
400
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 15, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • a) Patient with ulcerative colitis or Crohn's disease reliably diagnosed according to the criteria of the DGVS (German Society for Digestive and Metabolic Diseases)
  • b) Age from 18 years
  • d) Treatment in the Department of Internal Medicine IV of the Heidelberg University Hospital at the time of sample collection
  • e) The patient is able to give consent.
  • f) Signed declaration of consent

Exclusion Criteria

  • Failure to meet the inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials